295 related articles for article (PubMed ID: 30195271)
1. Risk factors for mortality after respiratory syncytial virus lower respiratory tract infection in adults with hematologic malignancies.
Vakil E; Sheshadri A; Faiz SA; Shah DP; Zhu Y; Li L; Kmeid J; Azzi J; Balagani A; Bashoura L; Ariza-Heredia E; Chemaly RF
Transpl Infect Dis; 2018 Dec; 20(6):e12994. PubMed ID: 30195271
[TBL] [Abstract][Full Text] [Related]
2. Refinement of estimates of mortality risk using the Radiologic Severity Index in hematologic malignancy patients with respiratory syncytial virus infection.
Sheshadri A; Karimipour M; Vakil E; Bashoura L; Godoy M; Arain MH; Evans SE; Dickey BF; Ost DE; Chemaly RF; Faiz SA
Transpl Infect Dis; 2019 Aug; 21(4):e13105. PubMed ID: 31081570
[TBL] [Abstract][Full Text] [Related]
3. Respiratory syncytial virus and human metapneumovirus after allogeneic hematopoietic stem cell transplantation: Impact of the immunodeficiency scoring index, viral load, and ribavirin treatment on the outcomes.
Akhmedov M; Wais V; Sala E; Neagoie A; Nguyen TM; Gantner A; von Harsdorf S; Kuchenbauer F; Schubert A; Michel D; Döhner H; Bunjes D
Transpl Infect Dis; 2020 Aug; 22(4):e13276. PubMed ID: 32162389
[TBL] [Abstract][Full Text] [Related]
4. Clinical Significance of Human Coronavirus in Bronchoalveolar Lavage Samples From Hematopoietic Cell Transplant Recipients and Patients With Hematologic Malignancies.
Ogimi C; Waghmare AA; Kuypers JM; Xie H; Yeung CC; Leisenring WM; Seo S; Choi SM; Jerome KR; Englund JA; Boeckh M
Clin Infect Dis; 2017 Jun; 64(11):1532-1539. PubMed ID: 28329354
[TBL] [Abstract][Full Text] [Related]
5. Immunodeficiency scoring index to predict poor outcomes in hematopoietic cell transplant recipients with RSV infections.
Shah DP; Ghantoji SS; Ariza-Heredia EJ; Shah JN; El Taoum KK; Shah PK; Nesher L; Hosing C; Rondon G; Champlin RE; Chemaly RF
Blood; 2014 May; 123(21):3263-8. PubMed ID: 24700783
[TBL] [Abstract][Full Text] [Related]
6. Mortality rates of human metapneumovirus and respiratory syncytial virus lower respiratory tract infections in hematopoietic cell transplantation recipients.
Renaud C; Xie H; Seo S; Kuypers J; Cent A; Corey L; Leisenring W; Boeckh M; Englund JA
Biol Blood Marrow Transplant; 2013 Aug; 19(8):1220-6. PubMed ID: 23680472
[TBL] [Abstract][Full Text] [Related]
7. Respiratory syncytial virus lower respiratory disease in hematopoietic cell transplant recipients: viral RNA detection in blood, antiviral treatment, and clinical outcomes.
Waghmare A; Campbell AP; Xie H; Seo S; Kuypers J; Leisenring W; Jerome KR; Englund JA; Boeckh M
Clin Infect Dis; 2013 Dec; 57(12):1731-41. PubMed ID: 24065324
[TBL] [Abstract][Full Text] [Related]
8. Supplemental Oxygen-Free Days in Hematopoietic Cell Transplant Recipients With Respiratory Syncytial Virus.
Waghmare A; Xie H; Kimball L; Yi J; Özkök S; Leisenring W; Cheng GS; Englund JA; Watkins TR; Chien JW; Boeckh M
J Infect Dis; 2017 Dec; 216(10):1235-1244. PubMed ID: 28961971
[TBL] [Abstract][Full Text] [Related]
9. Successful systemic high-dose ribavirin treatment of respiratory syncytial virus-induced infections occurring pre-engraftment in allogeneic hematopoietic stem cell transplant recipients.
Gueller S; Duenzinger U; Wolf T; Ajib S; Mousset S; Berger A; Martin H; Serve H; Bug G
Transpl Infect Dis; 2013 Aug; 15(4):435-40. PubMed ID: 23692664
[TBL] [Abstract][Full Text] [Related]
10. Respiratory viral infections in adults with hematologic malignancies and human stem cell transplantation recipients: a retrospective study at a major cancer center.
Chemaly RF; Ghosh S; Bodey GP; Rohatgi N; Safdar A; Keating MJ; Champlin RE; Aguilera EA; Tarrand JJ; Raad II
Medicine (Baltimore); 2006 Sep; 85(5):278-287. PubMed ID: 16974212
[TBL] [Abstract][Full Text] [Related]
11. Oral Versus Aerosolized Ribavirin for the Treatment of Respiratory Syncytial Virus Infections in Hematopoietic Cell Transplant Recipients.
Foolad F; Aitken SL; Shigle TL; Prayag A; Ghantoji S; Ariza-Heredia E; Chemaly RF
Clin Infect Dis; 2019 May; 68(10):1641-1649. PubMed ID: 30202920
[TBL] [Abstract][Full Text] [Related]
12. Respiratory syncytial virus infection in patients with hematological diseases: single-center study and review of the literature.
Khanna N; Widmer AF; Decker M; Steffen I; Halter J; Heim D; Weisser M; Gratwohl A; Fluckiger U; Hirsch HH
Clin Infect Dis; 2008 Feb; 46(3):402-12. PubMed ID: 18181739
[TBL] [Abstract][Full Text] [Related]
13. Leukopenia and lack of ribavirin predict poor outcomes in patients with haematological malignancies and respiratory syncytial virus infection.
Azzi JM; Kyvernitakis A; Shah DP; El Haddad L; Mahajan SN; Ghantoji SS; Heredia-Ariza E; Chemaly RF
J Antimicrob Chemother; 2018 Nov; 73(11):3162-3169. PubMed ID: 30113677
[TBL] [Abstract][Full Text] [Related]
14. Lower Respiratory Tract Diseases Caused by Common Respiratory Viruses among Stem Cell Transplantation Recipients: A Single Center Experience in Korea.
Hong KW; Choi SM; Lee DG; Cho SY; Lee HJ; Choi JK; Kim SH; Park SH; Choi JH; Yoo JH; Lee JW
Yonsei Med J; 2017 Mar; 58(2):362-369. PubMed ID: 28120567
[TBL] [Abstract][Full Text] [Related]
15. Treatment stratification of respiratory syncytial virus infection in allogeneic stem cell transplantation.
Balassa K; Salisbury R; Watson E; Lubowiecki M; Tseu B; Maouche N; Jeffery K; Misbah SA; Benamore R; Rowley L; Barton D; Pawson R; Danby R; Rocha V; Peniket A
J Infect; 2019 Jun; 78(6):461-467. PubMed ID: 30965067
[TBL] [Abstract][Full Text] [Related]
16. Impact of aerosolized ribavirin on mortality in 280 allogeneic haematopoietic stem cell transplant recipients with respiratory syncytial virus infections.
Shah DP; Ghantoji SS; Shah JN; El Taoum KK; Jiang Y; Popat U; Hosing C; Rondon G; Tarrand JJ; Champlin RE; Chemaly RF
J Antimicrob Chemother; 2013 Aug; 68(8):1872-80. PubMed ID: 23572228
[TBL] [Abstract][Full Text] [Related]
17. Risk factors for severe respiratory syncytial virus disease in children with cancer: the importance of lymphopenia and young age.
El Saleeby CM; Somes GW; DeVincenzo JP; Gaur AH
Pediatrics; 2008 Feb; 121(2):235-43. PubMed ID: 18245413
[TBL] [Abstract][Full Text] [Related]
18. Evaluation of prognostic scores for respiratory syncytial virus infection in a French multicentre cohort of allogeneic haematopoietic stem cell transplantation recipients.
Houist AL; Bondeelle L; Salmona M; LeGoff J; de Latour RP; Rivière F; Soler C; Houdouin V; Dalle JH; Robin C; Fourati S; Griscelli F; Coman T; Chevret S; Bergeron A
Bone Marrow Transplant; 2021 Dec; 56(12):3032-3041. PubMed ID: 34548625
[TBL] [Abstract][Full Text] [Related]
19. Ribavirin treatment for respiratory syncytial virus infection in patients with haematologic malignancy and haematopoietic stem cell transplant recipients: a systematic review and meta-analysis.
Manothummetha K; Mongkolkaew T; Tovichayathamrong P; Boonyawairote R; Meejun T; Srisurapanont K; Phongkhun K; Sanguankeo A; Torvorapanit P; Moonla C; Plongla R; Kates OS; Avery RK; Nematollahi S; Permpalung N
Clin Microbiol Infect; 2023 Oct; 29(10):1272-1279. PubMed ID: 37116860
[TBL] [Abstract][Full Text] [Related]
20. Respiratory syncytial virus in hematopoietic cell transplant recipients and patients with hematologic malignancies.
Khawaja F; Chemaly RF
Haematologica; 2019 Jul; 104(7):1322-1331. PubMed ID: 31221784
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
